Babson Diagnostics announces its Scientific Advisory Board
July 30, 2019
Austin, Texas - Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, has established its Scientific Advisory Board. Drs. Alan Wu, Susan A. Evans, and Robert H. Christenson will join the Babson team as scientific advisors.
Dr. Alan Wu is both a Professor of Laboratory Medicine at UCSF and Chief of Clinical Chemistry and Toxicology Laboratories at San Francisco General Hospital. He was awarded the American Association for Clinical Chemistry Outstanding Contributions to Education Award in 2002, as well as the IVD Technology’s Top Ten Persons in the IVD Industry in 2005.
Dr. Susan Evans, Principal and Founder of BioDecisions Consulting, was previously Vice President of Scientific Affairs at Beckman Coulter. She has 30 years’ experience in diagnostics and laboratory medicine, and was honored with the American Association for Clinical Chemistry Outstanding Lifetime Achievement Award in 2017.
Dr. Robert H. Christenson, Professor of Pathology and Medical and Research Technology at the University of Maryland, is also the Medical Director of Core Laboratories. He has over 35 years of experience in directing academic clinical laboratories. An international expert in cardiac biomarkers and clinical utility, he serves as Editor-in-Chief of The Journal of Applied Laboratory Medicine.
These three celebrated scientists will contribute their experience and expertise to guide Babson Diagnostics.
About Babson Diagnostics
Babson Diagnostics is a healthcare technology company focused on moving laboratory testing to the pharmacy counter. Babson has developed a model for diagnostic blood testing that maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods.